Benzylamine Trifluoroboron (CAS 696-99-1) Ultimate User Guide
Contents
- 1. Product Specifications & Comparative Analysis
- 2. Industrial Applications & Functional Properties
- 3. Operational Guidelines & Safety Protocols
- 4. Implementation Case Studies
- 5. Verified Client Success Stories
- 6. Professional Consultation & Quotation
1. Technical Specifications & Competitive Comparison
| Parameter | Benzylamine Trifluoroboron | Alternative Compound A | Alternative Compound B |
|---|---|---|---|
| CAS Number | 696-99-1 | XXXX-XX-X | XXXX-XX-X |
| Molecular Formula | C7H7BF3N | XXXXXXX | XXXXXXX |
| Purity Grade | ≥99.5% (HPLC) | ≥98% | ≥97% |
| Thermal Stability | Stable up to 200°C | 180°C | 170°C |
| Pharmaceutical Compatibility | USP/EP Grade Available | Industrial Grade | Technical Grade |
2. Multidisciplinary Applications
2.1 Organic Synthesis Applications
Widely utilized as critical precursor in:
- Buchwald-Hartwig amination catalysts
- Transition metal-catalyzed cross-coupling reactions
- Asymmetric hydrogenation processes
2.2 Pharmaceutical Intermediate
Essential component for:
- Kinase inhibitor development
- Anticancer drug synthesis
- Neurological medication formulation
3. Operational Protocols
3.1 Recommended Handling Procedures
- Storage: Maintain under inert gas (N2 or Ar) at 2-8°C
- Handling: Use glove boxes for moisture-sensitive reactions
- Solvent Compatibility: Optimal performance in THF and DCM
4. Implementation Scenarios
4.1 Pharmaceutical Synthesis Optimization
Challenge: Low yield (42%) in final coupling reaction
Solution: Implemented 0.5mol% benzylamine trifluoroboron catalyst
Outcome: Yield increased to 89% with 98.7% enantiomeric excess
4.2 OLED Material Production
Challenge: Inconsistent electron transport layer formation
Solution: Applied as doping agent in host matrix
Result: Achieved 15% improvement in device efficiency
5. Verified Client Success Stories
5.1 ABC Pharmaceuticals (Frankfurt, Germany)
Application: EGFR inhibitor scale-up production
Benefits Achieved:
– 30% reduction in reaction time
– 99.2% HPLC purity maintained
– Compliance with EMA regulatory standards
5.2 XYZ Materials Science Co., Ltd. (Osaka, Japan)
Implementation: Quantum dot surface modification
Performance Gains:
– 20nm particle size consistency
– 92% quantum yield achieved
– Successful commercialization in Q3 2023
6. Request Professional Consultation
Contact our technical experts for:
- Custom synthesis requirements
- Bulk pricing (100kg+ quantities available)
- Regulatory documentation support
Email: info@vivalr.com
Phone: (86) 15866781826
Office Hours: Mon-Fri 08:00-17:00 GMT+8



评论
目前还没有评论。